About this trial
Screening for risk factors related to lung function impairment in patients who have recovered from AIDS with severe pneumonia, to provide clinical evidence for early identification and intervention of lung function damage in this population.
Eligibility criteria
Qualifiers
Confirmed HIV infection;
Progression to the AIDS stage: CD4+ count <200 cells/µL and/or occurrence of opportunistic infections associated with AIDS;
Age between 18 to 65 years;
Meet the diagnostic criteria for severe pneumonia, with reference to the 2021 treatment guidelines for community-acquired pneumonia developed by the American Thoracic Society (ATS) and the Infectious Diseases Society of America (IDSA).
Disqualifiers
Concurrent central nervous system lesions, severe liver disease, or cirrhosis;
Concurrent AIDS-related or non-related tumors;
Women who are pregnant or breastfeeding;
Presence of serious underlying diseases such as heart, lung, liver, kidney, etc.;
Trial design
Treatments tested in this trial
- Not listed